Skip to content

Clinical trials

Phase 3 HIV Infections trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: HIV Infections Phase: Phase 3 Country / region: Australia Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20031
20053
20072
20083
20091
20104
20114
20121
20132
20153
20163
20172
20181
20203
20231
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Active, not recruiting5
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ViiV Healthcare14
Gilead Sciences9
Bristol-Myers Squibb4
Kirby Institute4
Abbott3
Merck Sharp & Dohme LLC3
Tibotec Pharmaceuticals, Ireland3
Boehringer Ingelheim2
National Institute of Allergy and Infectious Diseases (NIAID)2
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
HIV Infections47
Acquired Immunodeficiency Syndrome11
Infections6
AIDS Dementia Complex1
AIDS-Related Opportunistic Infections1
Cytomegalovirus Infections1
Disease Progression1
Dyslipidemias1
Hyperlipidemias1
Sarcoma, Kaposi1

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.